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Abstract 
The pathogenic properties of Enteroaggregative Escherichia coli strain 042 results from the synchronised 
expression of virulence factors, which include the Plasmid Encoded Toxin. Pet is a member of the serine 
protease autotransporter of the Enterobacteriaceae family and contributes to infection by cleaving α-fodrin, 
disrupting the actin cytoskeleton of host cells. The expression of Pet is induced by global transcription factor 
CRP with further enhancement by the nucleoid associated protein Fis. This study identifies the residues of RNA 
polymerase, Fis and CRP required for the induction of transcription, thereby clarifying the mechanism of 
activation employed by the transcription factors. Fis activates transcription from the Fis binding site via a direct 
interaction with RNA polymerase, facilitated by protein specific determinants. This interaction is dependent on 
the position of the Fis binding site on the DNA and it subsequent orientation on the helical face of the DNA. 
CRP induces transcription from its binding site via direct interactions with RNA polymerase, facilitated by 
protein specific determinants.  
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1.1 Escherichia coli   
Escherichia coli is a rod-shaped, gram-negative, facultative anaerobe of the class gammaproteobacteria. E. coli 
specifically colonises endotherms as a commensal or strict pathogen depending on the strain; commensal 
colonisation of the human lower gastro-intestinal (GI) tract occurring soon after birth (Bettelheim et al. 1974). 
Transmission occurs through an oral-faecal route, with sporadic transition through water and sediment, between 
hosts; environmental sources such as these are estimated at harbouring half of the entire E. coli population 
(Savageau 1983; Luna et al. 2010). Within this environmental population, there are thought to be strains present 
that are functioning saprophytes (Solo-Gabriele et al. 2000; Power et al. 2005). Due to the ease of cultivation 
and manipulation within the laboratory, the genome of E. coli was one of the first sequenced; cementing E. coli 
K12 as a founding pillar of modern molecular microbiology (Blattner et al. 1997). 
 
In the human intestine a myriad of bacteria make up the microbiota, with the following distribution of phylum: 
Firmicutes (64%), Bacteroidetes (23%), Proteobacteria (8%), Actinobacteria (3%), and other minor taxonomic 
divisions where high diversity is observed (Eckburg et al. 2005). The host and its gut flora have a symbiotic 
relationship. This deep rooted relationship is exemplified by the dependence of the host on its intestinal 
microbiota, which expresses genes that are functionally essential for but absent from the host (Backhed et al. 
2005; Gill et al. 2006; Kurokawa et al. 2007; Claus et al. 2011). This symbiotic relationship also provides 
protection against pathogenic organisms, since nutritional niches and attachment sites of the host gut are 
monopolised by the resident commensal community (Hudault et al. 2001; Asahara et al. 2004; Stecher et al. 
2007; Leatham et al. 2009). Humans, at any one time, can be simultaneously colonised by at least several 
commensal E. coli strains. This includes a resident strain that is typically predominant and present for months, or 
years, as well as transient strains, that are present for only a few days or weeks (Sears et al. 1950; Sears and 
Brownlee 1952; Sears et al. 1956; Bettelheim et al. 1972; Caugant et al. 1981). These commensal strains are 
located within the mucosa of the large intestine, specifically, in the caecum and the colon. In this nutritional 
niche E. coli is the predominant facultative anaerobe, making up 0.1% of the indigenous microbiota (Freter et al. 
1983; Poulsen et al. 1994; Eckburg et al. 2005). The predominance of E. coli, in the niche of the mucosa, is 
thought to have arisen due to the efficiency with which it utilises gluconate for respiration, via anaerobic mixed 
acid fermentation (Sweeney et al. 1996; Chang et al. 2004). 
 
 
The interior of E. coli cells consist of the liquid cytoplasm, within which the majority of the macromolecular 
machinery of the cell resides; enabling cell growth, metabolism, and replication (Vendeville et al. 2011). The 
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cytoplasm is encased by a sheath of an inner and outer membrane, separated by an intermediary periplasmic 
space, containing peptidoglycan. The outer membrane is in contact with the external environment and acts as a 
selective barrier; facilitating the uptake of beneficial molecules whilst excluding harmful molecules. Proteins 
including flagella, adhesins, pores, sensors, amongst others are dotted across the outer membrane, imbued with 
diverse functions (van Bloois et al. 2011). Some strains also possess an extracellular complex polysaccharide 
structure, the capsule, which protects the cell from desiccation and phagocytosis whilst also promoting 
adherence to host cells (Whitfield 2006; Beloin et al. 2008). 
 
E. coli has a circular, double-stranded DNA genome which forms a distinct structured unit within the cytoplasm, 
the nucleoid. The nucleoid is a complex consisting of the DNA genome, encoding the genes required for the 
survival of the organism; and the nucleoid associated proteins (NAPs) that maintain the structure of the nucleoid 
and modulate gene expression (Reyes-Lamothe et al. 2008; Browning et al. 2010). The genomes of many E. coli 
strains have now been sequenced and comparisons between these strains highlight the wide diversity within the 
species. K12 MG1655 contains 4288 annotated protein coding genes with anywhere between 4000 and 5500 
genes in related strains (Blattner et al. 1997). Surprisingly, when 207 E. coli isolates were compared, a core set 
of only 2256 genes were common to all strains (Jackson et al. 2011). The remaining portion of each genome is 
comprised from a mosaic of insertions and deletions, fabricated from a heterogeneous mix of the 18000 genes of 
the dispensable genome (Rasko et al. 2008; Touchon et al. 2009). The phenotypic plasticity observed between 
strains is caused by variation in the combination of genes, from the pan-genome, in the strains dispensable 
genome. 
 
1.2 Pathogenic Escherichia coli  
The genomes of pathogenic E. coli differ from commensal strains in size and content, where the genomes can be 
up to 1 Mbp larger, due to the loss and gain of superfluous pan-genomic elements. The evolutionary move from 
commensal to pathogen is initiated by the acquisition of virulence factors which enhance microbial transmission, 
survival or colonisation, in context of the host, followed by the loss of genomic elements required for 
environmental survival reducing the viability of the organism outside of the host (Hacker and Kaper 2000; 
Ochman and Jones 2000; Hong et al. 2012). Following selective pressures, resulting from the exposure to the 
host immune system, which selects for variants that can deal with these pressures; these variants tend to have 
higher mutation and recombination rates, although this phenotype tend to tail away after beneficial mutations are 
gained (Cooper and Lenski 2000; Denamur et al. 2000; Wirth et al. 2006; Woods et al. 2011).  
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The evolution of bacterial genomes can occur endogenously, through mutations, rearrangements and gene 
duplication or exogenously by horizontal gene transfer (HGT) (Chopra et al. 2003; Matias Rodrigues and 
Wagner 2009). Mobile elements including plasmids, transposons and bacteriophages, are transferred between 
organisms by HGT, transferring DNA sequences, corresponding to single genes or several genes, to the recipient. 
Some of these genes may contribute, directly or indirectly, to the pathogenicity of a bacterium; although the 
classification of a factor being virulent is arbitrary as a factor that promotes virulence in the host may also 
promote fitness in the environment, virulence depends upon environmental context (Groisman and Ochman 1996; 
Hacker et al. 1997; Croxen and Finlay 2010). The loss and gain of mobile elements can influence the evolution 
of the bacterial genome, with the gain of genomic islands or single genes permitting the rapid acquisition of new 
traits; including amongst others, resistance to antimicrobials,
 
or the
 
ability to colonise and promote virulence 
within a host (Waldor et al. 1996; Boltner et al. 2002; Herold et al. 2004; Anantham and Hall 2012). The 
acquisition of these traits can bestow a pathogenic phenotype or provide access to previously occluded niches 
within a host, uncovering an evolutionary path geared towards the generation of pathogenic organisms. These 
mechanisms of gene acquisition, and subsequent selective pressures, have resulted in eight separate pathovars of 
E. coli which can colonise and cause disease within the GI tract, urinary tract or meninges; depending on the 
bespoke assortment of virulence factors ascribed to each of the pathovars. The six diarrhoeagenic pathovars are 
enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC). The 
two extraintestinal pathovars are uropathogenic E. coli (UPEC) and meningitis-associated E. coli that cause 
urinary tract infections and meningitis/sepsis respectively.  
 
E. coli pathovars all share a common strategy in their pathogenesis and often target the same host machinery, 
although the individual mechanisms and virulence factors employed vary (Finlay and Falkow 1997; Croxen and 
Finlay 2010). This strategy starts with adherence to host cells, followed by proliferation and distribution 
throughout the host, aided by virulence factors that aid evasion of host defences or improve the competiveness of 
the pathogen to the host microbiome, occasionally causing damage to the host (Betancourt-Sanchez and 
Navarro-Garcia 2009; Shames and Finlay 2010). Pathogenicity is not achieved by any single virulence factor, 
rather it requires an ensemble; with regulatory factors synchronising the expression of virulence factors, in 
response to extracellular physiochemical stimuli, to be expressed in the right place at the right time. Virulence 
factors are regulated in response to physiochemical signals indicative of the host, inducing the cascade of 
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required factors to promote bacterial survival and proliferation. The regulons of the regulatory factor can overlap 
allowing multiple inputs to modulate the activities of specific genes, tuning their expression. Inductions of 
virulence genes are frequently regulated by pathogen-specific transcriptional regulators encoded on PAIs or 
plasmids or by regulators present in commensal E. coli providing a link between essential cellular processes and 
virulence. Taken together, a picture emerges where a constantly changing extracellular physiochemical signals 
are responsively countered by constantly fluctuating gene expression; the virulence factors expressed supporting 
the survival of the organism whilst also resulting in pathogenicity.  
 
1.3 Gene Expression 
Gene expression is the process by which a gene is firstly transcribed, where a strand of RNA whose sequence is 
complementary to the template strand of the gene is assembled; sequential translation, yields any resultant 
protein. Gene expression is regulated in response to extracellular physiochemical stimulus, adjusting the cells 
gene expression profile; ensuring survival. Regulation can occur at any stage of gene expression; interfering with 
the steps of the transcription and translation cycles or altering the half-life of the RNA transcript or the resultant 
protein. Transcription, is the first step in gene expression and therefore offers the most economical point for 
regulation to occur; the most common regulatory target being the initiation of transcription. Transcription is 
reliant upon RNA polymerase (RNAP), an enzyme which synthesises RNA complementary to the DNA template 
of the genome.  
 
The E. coli core RNAP enzyme shares significant sequence and structural homology with its archaeal and 
eukaryotic homologs, which all resemble a ‘crab claw’; yet the composition of the subunits that form this claw 
differ between species (α2ββ΄ω subunits for E. coli core RNAP) (Figure 1.1a) (Ebright et al. 1985; Ebright et al. 
1990; Zhang and Ebright 1990; Parkinson et al. 1996; Passner and Steitz 1997; Chen et al. 2001). The pincers of 
the claw are formed by the β and β′ subunits, separated by a ∼27 Å cleft, with the active centre at the base cleft 
containing the two crucial Mg
2+
 ions needed for nucleotide addition cycle during transcript elongation. Two α 
subunits are present, each binding either β (αI) or β' (αII), and form a dimer, holding the complex together 
(Ebright et al. 1984; Passner and Steitz 1997). Each α subunit consists of two domains connected by a flexible 
linker: an N-terminal domain (αNTD) responsible for dimerisation and interaction with β' and β subunits, and a 
C-terminal domain (αCTD) able to interact with promoter DNA and transcription factors 
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Figure 1.1: Structural overview of RNAP and σ (Borukhov and Nudler 2003; Ghosh et al. 2010) 
(a) Crystal structure of Thermus aquaticus RNAP core (left) and holoenzyme (right) (b) Cartoonised 
representation of RNAP holoenzyme (c) The major transitional steps formed on the progression from the core 
RNAP to EC (d) σ70 family domain map, with major domain regions label with names and their interaction 
partners. (RNAP subunit colours: αI, light grey; αII, grey; β, light brown; β’, light green; ω, dark green; σ, 
magenta)  
(d) 
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(Caddick et al. 1986; Johnson et al. 1986a; Ishihama 1992; Browning et al. 2010). The small ω subunit interacts 
exclusively with β' near the base of the pincer, acting as a chaperone, maintaining the required conformation of 
β' to be incorporated into the α2β complex during the formation of the core enzyme (Ghosh et al. 2001; Ghosh et 
al. 2003; Mathew and Chatterji 2006). 
 
1.4 The Transcription Cycle 
Transcription can be separated into 3 major steps each characterised by several structural transitions of RNAP; 
formation of the initiation complex and promoter clearance, transcript elongation and termination. For 
transcription to occur the elongation complex (EC) must be assembled and translocated along the DNA, 
catalysing the synthesis of the RNA transcript as it goes (Figure 1.1c) (Ebright et al. 1987). Initially RNAP binds 
the promoter DNA, just upstream of the gene, forming the closed initiation complex (RPc), isomerisation of 
which gives the open initiation complex (RPo) able to transition to the subsequent Elongation Complex (EC). 
Termination of transcription is facilitated by various mechanisms, all of which cause RNAP to release the RNA 
transcript and DNA template, ready for the next round of transcription. 
 
1.4.1 Formation of the Initiation Complex 
The core RNAP enzyme is catalytically competent for transcription, but the complex still lacks the essential 
ability to bind specifically and strongly to promoter DNA (Ishihama 1990). Transient binding of a σ factor to the 
core to form the holoenzyme, imbuing the complex with ability to bind, specificity, to promoters within the σ 
factors regulon, whilst inhibiting nonspecific DNA interaction (Figure 1.1a,b) (Parkinson et al. 1996; Ferguson 
et al. 2000; Wade et al. 2006). Bacteria can encode multiple σ factors, belonging to either the σ70 or σ54 family; 
which differ in sequence, structure and mechanism of transcription initiation (Wosten 1998; Ghosh et al. 2010). 
In E. coli, σ70 is the housekeeping σ factor; its regulon encompassing the genes required for normal growth 
(Reppas et al. 2006). σ70 family factors are formed of four conserved domains (σ1, σ2, σ3 and σ4) connected by 
flexible linkers (Figure 1.1 d) (Lonetto et al. 1992; Campbell et al. 2002; Paget and Helmann 2003). σ70 binds the 
RNAP core through several independent contacts; the σ2 region conveying the major contact with the β’ (Zhang 
and Ebright 1990; Malhotra et al. 1996; Severinova et al. 1996; Sharp et al. 1999; Campbell et al. 2002; Opalka 
et al. 2010). When σ is unbound, the σ1.1region mimics DNA, occluding the regions essential for promoter 
binding (σ2 and σ4), inhibiting promoter association; upon formation of the holoenzyme, σ1.1 undergoes a 
conformational change becoming located within the active-site channel of RNAP, exposing σ2 and σ4, de-
 
 
8 
 
repressing promoter recognition (Dombroski et al. 1993; Parkinson et al. 1996; Gopal and Chatterji 1997; 
Bowers and Dombroski 1999; Mekler et al. 2002).  
 
Following its formation, the holoenzyme tracks along the DNA until it locates a promoter; characterised by a set 
of promoter sequence elements, specific for the bound σ factor, each of which conveys an additive contribution 
to binding, forming the resultant RPc (Guthold et al. 1999; Sakata-Sogawa and Shimamoto 2004; Miroslavova 
and Busby 2006; Hook-Barnard and Hinton 2007). σ70 promoters possess the hexameric elements, −35 and −10, 
separated by a spacer of 17(±1) nt (consensus sequences 
-35
TTGACA
-30
 and 
-12
TATAAT
-7 
respectively), which 
interact with σ4.2 and σ2.4 respectively (Rosenberg and Court 1979; McClure 1985; Siegele et al. 1989; Lisser 
and Margalit 1993; Dombroski 1997). The precise sequence of the spacer normally has little impact on 
transcription but strict conservation of the length is essential (deHaseth and Helmann 1995; Hook-Barnard and 
Hinton 2009; Singh et al. 2011; Sztiller-Sikorska et al. 2011; Yuzenkova et al. 2011). Besides the −10 and −35 
elements, other elements can be present such as extended −10 (-15TGn-14) and the GC-rich discriminator (ranging 
from positions +1 to +20), both of which interact with σ70, and the UP element (variable region upstream of the -
35 element) which interacts with the αCTD (Travers 1984; Ross et al. 1993; Barne et al. 1997; Estrem et al. 
1998; Burr et al. 2000; Mitchell et al. 2003; Haugen et al. 2008). Promoters generally contain a combination of a 
few, but not all, of these elements, each of which contributes to the affinity of the holoenzyme to the promoter.  
The following step, the isomerisation of RPc to RPo, is initiated by the melting of the DNA duplex at the -10 
position. This and subsequent steps are driven by the favourable transition from RPc to RPo (Feklistov and Darst 
2011; Chakraborty et al. 2012). Upon melting, the highly conserved -11A, of the -10 element flips, associating 
with σ2.3, stabilising the melted conformation of the strand and forming the upstream edge of the transcription 
bubble (Matlock and Heyduk 2000; Chen et al. 2001; Lim et al. 2001; Lee et al. 2004; Schroeder et al. 2008; 
Schroeder et al. 2009). The template strand is then loaded into the active site of RNAP, interacting with σ2.3 
further contributing to stability of the transcription bubble (Aiyar et al. 1994; Chen et al. 2001; Murakami and 
Darst 2003). The dsDNA downstream of the -10 element scrunches into the active-site channel, further opening 
the transcription bubble from -10 to +2, whilst strain accumulates (Chen et al. 2010). This strain is released by 
the bending and kinking of downstream DNA (Rees et al. 1993; Rivetti et al. 1999). The bent dsDNA is loaded 
into the active-site channel by a proposed “rope-swing” mechanism, where repulsion between the dsDNA and 
σ1.1 stimulates segments of β subunit to transiently rearrange, widening the active-site channel sufficiently for 
loading the dsDNA (Murakami and Darst 2003; Chen et al. 2010). The width of the channel is restored, 
following the loading of the DNA, locking it firmly in place, displacing σ1.1 from the channel; denoting the first 
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step towards the dissociation of σ from the core (Mekler et al. 2002; Chen et al. 2010). The isomerisation event 
concludes, when the +1 transcription start site is aligned in the correct position of the active site, ready for 
transcription (Naryshkin et al. 2000; Chen et al. 2001; Murakami and Darst 2003; Vignon et al. 2003).  
 
1.4.2 Promoter Clearance 
Upon formation of the RPo, NTP is supplied to the active site through the secondary channel, initiating the 
nucleotide addition cycle and initial synthesis of the RNA transcript. During this time RNAP remains stationary, 
bound to the promoter, and the downstream template DNA, required for transcript elongation, is scrunched into 
the complex, accumulating stress (Straney and Crothers 1987; Cheetham and Steitz 1999; Kapanidis et al. 2006; 
Revyakin et al. 2006; Tang et al. 2008). As the transcript length reaches 12 nt it encounters the RNA exit 
channel, which is blocked by σ3.2, and the releasing of the accumulated stress leads to one of two outcomes; the 
transcript can successful dislodge the σ3.2 loop and synthesis can continue or the synthesis of the transcript can 
be aborted (Cashel et al. 2003; Murakami and Darst 2003; Kulbachinskiy and Mustaev 2006). Normally the 
transcript is unsuccessful in dislodging the σ3.2 loop, with successive failure resulting in the production of many 
short abortive transcripts (<12 nt); promoters with the highest consensus sequences have the highest affinity 
association between the promoter and holoenzyme, preventing dissociation and resulting in extensive abortion 
(Hsu et al. 2003; Vo et al. 2003; Miroslavova and Busby 2006). After reaching a length of 12 nt and displacing 
the σ3.2 loop, the transcript, must reach a length of 16–17 nt and displace σ4, which partly occludes the end of 
the RNA exit channel(Parkinson et al. 1996; Geszvain et al. 2004; Gregory et al. 2005). σ remains bound to the 
core only through the interactions of σ2, the σ2-3 linker, and σ3 the stochastic loss of which results in the total 
dissociation of σ, permits translocation, signifying the formation of the EC. Occasionally σ can remaining bound 
to the core, translocating for significant distances, and contributing to proximal-pausing (Shimamoto et al. 1986; 
Chen and Ebright 1993; Ring et al. 1996; Brodolin et al. 2004; Kapanidis et al. 2005; Raffaelle et al. 2005). 
 
1.4.3 Elongation 
Following promoter escape, transcript elongation occurs with transient pauses punctuating transcript synthesis; 
occurring when there is misalignment of the additive nucleotide, downstream promoter-like elements or the EC 
adopts the elemental pause conformation (Ring et al. 1996; Adelman et al. 2002; Herbert et al. 2006; Xie 2008; 
Walmacq et al. 2009). Entry into the elemental pause conformation occurs through the isomerisation of the 
active site causing inhibition of nucleotide addition, where the conformation of the G (trigger)-loop is altered, 
which normally acts in tandem with the F (bridge)-helix, facilitating nucleotide addition through a brownian 
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ratchet mechanism (Komissarova and Kashlev 1997; Abbondanzieri et al. 2005; Bar-Nahum et al. 2005; 
Toulokhonov et al. 2007; Xie 2008; Landick 2009). Pausing can be prolonged by transcript backtracking, RNA 
hairpin formation or regulator binding (Chan and Landick 1989; Artsimovitch and Landick 2000; Artsimovitch 
and Landick 2002; Bai et al. 2004; Landick 2009; Maoileidigh et al. 2011). RNAP can be restored to an active 
conformation, from the backtracked state, by GreB or Mfd, which restore the 3’ register of the transcript within 
the active site; entry into a paused confirmation is partially prevented by GreA (Borukhov et al. 1993; Selby and 
Sancar 1993; Marr and Roberts 2000; Toulme et al. 2000; Park et al. 2002; Laptenko et al. 2003; Roberts and 
Park 2004). GreB binds RNAP, inserting a Mg
2+ 
topped protrusion through the secondary channel, swapping 
with and acting as a substitute for the G(trigger)-loop, cleaving the nascent RNA, generating a new 3′-terminus 
(Steitz and Steitz 1993; Opalka et al. 2003; Sosunova et al. 2003; Vassylyeva et al. 2007; Roghanian et al. 
2011). Mfd binds the duplex DNA immediately upstream of the transcription bubble, binding RNAP and then 
ratchets the RNAP forward, causing the reversal of the backtracking until the 3’ terminus is in proper register 
within the active site or in an intractable roadblock causing RNAP to dissociates from the DNA (Roberts and 
Park 2004). Pausing is a necessary part of elongation as it allows translation to be coupled with transcription 
through the interaction between the RNAP bound NusG, and the ribosomal NusE; preventing prolonged pausing 
and Rho-dependent termination.  
 
1.4.4 Termination 
Throughout elongation the EC enters pause phases, although the complex is rescued, resuming transcription, but 
distinct sequence signals causes a pause that cannot be rescued; committing the EC to the transcription 
termination pathway (McDowell et al. 1994; Gusarov and Nudler 1999; Peters et al. 2011). These signals are 
either intrinsic, dependent upon the interactions between the EC and the transcript, or dependant on the 
recruitment and subsequent action of the Rho factor (Epshtein et al. 2007; Epshtein et al. 2010). The intrinsic 
mechanism of termination requires the presence of a conserved termination sequence; GC-rich inverted repeat 
followed by a track of U at the 3’ terminus of the transcript (Brendel et al. 1986; Telesnitsky and Chamberlin 
1989; Martinez-Trujillo et al. 2010). When transcribed, the U-track induces pausing providing the time for the 
inverted repeat region to hybridise and form a strong hairpin in the RNA exit channel (Gusarov and Nudler 
1999). Hairpin formation is facilitated by the increased thermodynamic stability over the DNA-RNA hybrid and 
is accommodated within the exit channel due to widening, facilitated by flexibility of parts within this region 
(zipper, flap, and zinc finger) inducing folding of G (trigger)-loop causing RNAP to enter a prolonged, stabilised 
pause (Farnham and Platt 1981; Epshtein et al. 2007; Toulokhonov et al. 2007). As the hairpin grows it is 
 
 
11 
 
relocates into the main channel, melting the DNA-RNA hybrid, and interacting with the G (trigger)-loop, locking 
the EC into a unrecoverable state, inducing the DNA-clamp to open, resulting in the release RNAP from both the 
DNA template and RNA transcript (Bar-Nahum et al. 2005; Vassylyev et al. 2007).  
 
Factor dependent terminating requires Rho, which forms as a homo-hexameric ring with the transcript loaded 
through its central cavity and translocates in a 5′→ 3′ direction along the transcript in an ATP dependant 
mechanism (Roberts 1969; Geiselmann et al. 1992; Adelman et al. 2006; Skordalakes and Berger 2006). 
Loading relies on the presence of a rut site; 70-80 nt length of C-rich, unstructured RNA (Morgan et al. 1985; 
Sharp et al. 1986; Alifano et al. 1991; Kim and Patel 2001). Subsequent binding of Rho to the EC is essential for 
termination, but whether Rho forms this complex prior to translocation or whether translocation precedes 
complex formation is unclear (Mooney et al. 2009; Epshtein et al. 2010; Kalyani et al. 2011). In either case the 
rates of translocation and transcription are coupled, so that the rate of translocation must exceed transcription for 
termination to occur (Jin et al. 1992; Sashni et al. 2012). Termination occurs exclusively within the termination 
region, 60–90 nt downstream of the rut site, which pauses the EC (Galloway and Platt 1988; Banerjee et al. 
2006; Ciampi 2006). The type of pause is important in Rho-dependant termination, with the ability of the paused 
EC to dissociation reduced, when due to irreversible backtracking or RNA hairpin formation (Kassavetis and 
Chamberlin 1981; Dutta et al. 2008). The release of the paused EC occurring only when the EC is restored to a 
catalytically competent state, by the forces produced by Rho through ATP-dependant translocation (Dutta et al. 
2008).  
 
1.4.5 Promoter Strength and Regulation of Promoters 
Bacteria can encode multiple σ factors, belonging to the σ70 or σ54 family. E. coli possesses one σ54 factor and six 
σ70 family factors (σ70, σ38, σ32, σ28, σ24, σ19) (Gruber and Gross 2003; Paget and Helmann 2003). Each σ factor 
has a degenerate regulons defined by presence of factor specific promoter elements. Under normal physiological 
conditions σ70 is highly expressed stimulating the expression of its regulon of housekeeping gene, when stricken 
by physiochemical stress, a stress response σ factor is expressed accessing its regulon, rapidly reprogramming 
the profile of gene expression to respond to the stress. Promoters within a regulon of each of the σ factors display 
varying “strengths”, with strong promoters inducing the highest levels of gene expression. The strength of a 
promoter is determined by the affinity of the promoter to RNAP and its isomerisation efficiency. Promoters 
become stronger as the conserved promoter elements (such as UP, −35, −10 and extended -10 elements for σ70) 
approach full consensus although this strength declines when the interactions between the RNAP and promoter 
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are sufficiently strong to hinder promoter escape (Miroslavova and Busby 2006). The quantities of available 
RNAP are limited and therefore prudent and adaptive distribution of RNAP to promoters is essential (Ishihama 
2000; Grainger et al. 2005). Therefore, promoters are made up of different combinations of non-consensus 
promoter elements; essential genes being the strongest and response specific genes weakest, but whose activity 
can be induced in response to stimuli by transcription factors.  
 
Transcription factors are responsible for the modulation of expression of a promoter in response to stimuli and 
therefore their expression and allosteric activation are regulated to avoid inappropriate cellular responses (Busby 
and Ebright 1997). Transcription factors affect the activity of a promoter negatively or positively by modulating 
the strength of the promoter; altering the affinity to RNAP or affecting the efficiency of the progression to the 
elongation complex. Transcription factors bind sequence specific sites within the promoter and directly or 
indirectly modulate promoter activity (Ishihama 1992; Kahramanoglou et al. 2011). The position of the 
transcription factor binding site is important where activators can repress from specific locations (Bendtsen et al. 
2011). Repressors bind downstream of promoters or over promoter elements interfering with transcription and/or 
elongation. Activators normally bind upstream of the RNAP binding elements increasing the affinity between the 
promoter and RNAP or supporting isomerisation. Activators can act via many diverse mechanisms at σ70-
dependent promoters, including class I and class II mechanism, functioning through direct interaction between 
the transcription factor and RNAP holoenzyme (Browning and Busby 2004). Class II activators increase 
promoter affinity by binding just upstream and overlapping the -35 element and interact with the proximal α 
subunit and often domain 4 of σ70 (Busby and Ebright 1997; Dove et al. 2003). Class I activators bind further 
upstream and interact with the distal α subunit; the position of the binding site can be variable due to the 
flexibility of the α subunits linker domain (Ebright 1993). Regulation of a promoter is not limited to one 
transcription factor; the combined input of multiple factors tunes a promoters' activity in response to a range of 
stimuli. Regulons of transcription factors can ranges in size, anywhere from 1 to 100+ promoters, the latter 
regulated by transcription factors coined global regulators (Martinez-Antonio and Collado-Vides 2003). Two 
such global regulators are the Factor for Inversion Stimulation (Fis) and cAMP Receptor Protein (CRP), each of 
which is expressed sequentially through growth; CRP during lag phase and Fis early log phase (Ball et al. 1992; 
Azam and Ishihama 1999).  
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1.4.6 cAMP Receptor Protein 
CRP is a global transcription regulator whose regulon is comprised of at least 180 genes with a diverse range of 
functions, many of which are involved in utilisation of secondary carbon sources (Grainger et al. 2005; 
Deutscher 2008). CRP forms a homodimer in solution, each dimer formed of two domains; the N-terminal 
domain (1–133) responsible for subunit dimerisation and cAMP binding and the C-terminal domain (139–209) 
for interactions with the palindromic 16 bp CRP DNA binding site (TGTGAnnnnnnTCACA) (Ebright et al. 
1989; Zhou et al. 1993; Parkinson et al. 1996; Lawson et al. 2004). CRP is allostericly activated by binding to a 
co-factor, cAMP, which is produced when glucose concentrations are low. When active, CRP binds to its 
binding site, exerting a 90-125° bend in DNA, flanking the binding site, altering the architecture of the promoter 
(Parkinson et al. 1996; Passner and Steitz 1997; Lin and Lee 2003; Popovych et al. 2009). Gene regulation, 
mediated by changes in promoter architecture, is common; were the position of additional transcription factors 
binding sites can be altered to allow, or disallow, the factor to contribute to transcription regulation. The position 
of the CRP DNA binding site in regards to a promoter determines the effect CRP has on the expression from a 
promoter; cAMP-CRP able to both induce and repress gene expression (Lawson et al. 2004). Transcription 
activation requires an interaction between RNAP the activating regions of CRP; activation region 1 (AR1) 
located in the C-terminal domain (αCTD) and activation region 2 (AR2) the N-terminal domain (Igarashi and 
Ishihama 1991; Zhou et al. 1994; Savery et al. 1996). Whether CRP induces or represses transcription depends 
on the position of the binding site; the optimum positions for activation, in respect to the transcription start site, 
being centred at position -41 for class II and positions -93, -83, -72, or -62 for class I (Tebbutt et al. 2002; 
Rossiter et al. 2011). CRP also represses transcription through promoter element occlusion, anti-activation or by 
hindering promoter clearance (Polayes et al. 1988; Mollegaard et al. 1993; Lee and Busby 2012). 
 
1.4.7 Factor for Inversion Stimulation 
The nucleoid is a distinct complex consisting of the genomes and several nucleoid associated proteins (NAPs) 
that maintain this structure and some of which affect gene (Browning et al. 2010). Fis is one such NAP, and is 
involved in a diverse set of cellular processes, including regulating transcription, maintaining nucleoid structure, 
site specific DNA inversion and modulating level of negative DNA topology (Johnson et al. 1986b; Ussery et al. 
2001). Fis exists as a homodimer that binds to its 15 bp binding site characterised by partial dyad symmetry and 
AT rich, degenerate sequence (Grainger et al. 2006; Shao et al. 2008). This binding inducing DNA bending 
between 40° and 90° which leads to the stabilisation of the supercoils of the DNA helix, compacting the DNA 
(Travers and Muskhelishvili 1998; Skoko et al. 2006). There are at least 894 Fis DNA binding regions scattered 
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throughout the genome within both promoter and intergenic regions; transcription regulation modulation 
occurring from a subset of these (Schneider et al. 2001; Grainger et al. 2006; Cho et al. 2008; Browning et al. 
2010). Fis is able to modulate transcription by directly affecting the activity of RNA polymerase or indirectly by 
modulating the level of negative DNA supercoiling (Travers and Muskhelishvili 1998; Skoko et al. 2006; 
Browning et al. 2010). Fis is able to affect transcription through stabilising negative supercoiling which captures 
RNAP which is aligned with the promoter element, this alignment generating positive writhe counteracting the 
negative supercoiling. Fis then causing the negative supercoil to be released, the stored torsion transmitted to 
RNAP; contributing to the isomerisation of the open complex to the Elongation Complex, and subsequent 
transcript elongation.    
  
1.5 Enteroaggregative Escherichia coli   
EAEC is a heterogeneous pathovar, characterised by the “stacked bricked” pattern of adhesion with which it 
adheres to HEp-2 cells; many strains of the pathovar have the ability to causes persistent watery diarrhoea 
(Nataro and Kaper, 1998; Nataro et al. 1998; Harrington, et al. 2006). When EAEC is subsequently mentioned in 
this work, it refers to the prototypical strain 042 (Chaudhuri et al.  2010). The pathogenesis of EAEC involves 
several distinct processes; adherence to intestinal mucosa, biofilm formation and toxin expression, facilitated by 
the coordinated expression of virulence factors (Wakimoto, et al. 2004; Harrington, et al. 2005; Nataro 2005.) 
The pAA plasmid encodes many of these virulence factors ; one of which is the prototypical SPATE (serine 
protease autotransporter of the Enterobacteriaceae), Pet (Eslava, et al. 1998; Henderson et al. 1999; Chaudhuri, 
et al. 2010). Pet contributes to the pathogenesis of EAEC strain 042 by targeting α-fodrin, disrupting the actin 
cytoskeleton of host cells (Eslava et al. 1998; Nataro 2005; Croxen and Finlay 2010). The action of Pet causes 
the homeostasis of the host gut to be disturbed allowing EAEC to outcompete the commensal flora, allowing 
EAEC to colonise the nutritional niche of the intestinal mucosa (Kamada et al. 2012).   
 
1.5.1 Plasmid Encoded Toxin 
The pet gene is encoded on the pAA plasmid of EAEC strain 042 and expressed during early exponential phase 
resulting in the secretion and accumulation of extracellular Pet (Betancourt-Sanchez and Navarro-Garcia 2009; 
Chaudhuri et al. 2010). Previous work has been done to assess aspects of transcription the pet promoter (Rossiter 
et al. 2011). A transposon mutagenesis library of EAEC was screened for strains deficient in Pet secretion; over 
150 candidates were identified, several of which had insertion in around the genes encoding the global 
transcription factors CRP and Fis (Rossiter et al. 2011). An in vitro transcription assay of region containing the 
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predicted translation start site of pet, was assessed to determine the location of transcription start site. The 
downstream of the transcription start site several potential promoter elements, including CRP and Fis DNA 
binding sites, were identified. In vitro footprinting was used to define the location of the DNA binding sites. One 
CRP binding site was shown to be centred -40.5 and two Fis binding sites centred -91 (fisI) and -122 (fisII), in 
respect to the transcription binding site.  
 
The contribution of each these sites on the expression from the pet promoter was assessed by the creation of 
several pet promoter derivatives contained single or double nucleotide substitution that knocked out each 
proposed promoter element individually. These promoter derivatives were cloned into a gene reporter system 
(pRW50) that allowed gene expression to be assessed by the observed functional activity of an expressed 
enzyme; β-galactosidase. The pet promoter was confirmed to possess several promoter elements; extended -10 
element, CRP DNA binding site and two Fis DNA binding sites. Both the extended -10 element and CRP DNA 
binding site were seen to be essential for transcription; when knocked out greatly showed drastically reduced the 
levels of expression.  The downstream Fis DNA binding site showed significantly reduced expression, but to a 
lesser extent. Suggesting transcription activation is mediated by CRP and enhanced by Fis, from the downstream 
Fis binding site, in a synergic manner. When the upstream Fis binding site was knocked out expression was seen 
to rise showing this site is repressive. An in vitro band shift assay was performed showing that the downstream 
Fis binding site has a higher affinity than that of the upstream site but both may be occupied at the same time.  
 
This work then proceeds, further defining the effects of CRP in the context of the pet promoter. CRP dependent 
induction was assumed to be directed via a class II activation mechanism, from CRP DNA binding site. An assay 
conducted in a Δcrp genetic background completed with plasmids contain CRP with either activating regions 
(AR1 and AR2) activity impaired; both regions impairments showed significantly reduced expression. The 
optimum position for CRP DNA binding site for class II transcription activation is centred at location -41.5 in 
respects to the transcription start site (Gaston et al. 1990). 1 bp was inserted between position −21 and −22 of the 
pet promoter to alter the position of the CRP binding site to the optimal position. The expression of this promoter 
was compared to that of the wild type in Δfis, Δcrp and wild type genetic backgrounds. The expression from this 
promoter was at equal levels in both Δfis background and wild type genetic backgrounds, meaning promoter is 
no longer activated by Fis and the contribution of CRP to transcription activation is increased.  
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1.6 Aims 
The previous work was able to identify the important promoter elements that regulate transcription at the pet 
promoter and provided some insights into the mechanisms of regulation. Transcription regulation at this 
promoter requires further investigation to clarify how CRP and Fis collaborate to modulate expression. Fis is 
seen to regulate from two DNA binding sites in the promoter but the mechanisms employed are unclear. 
Furthermore, the dependence on CRP for the activation due to Fis has not been addressed. The aims of this work 
are to firstly elucidate how Fis induces transcription from the downstream Fis binding site. Secondly, the 
mechanism of repression employed by Fis bound to the upstream site will be assessed. Finally, any suspected 
interactions between RNAP and transcription factors will be assessed to identify specific determinants to 
confirm the presence of class I or II interactions.   
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Materials and Methods 
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2.1 Suppliers 
Unless stated otherwise, all chemicals were ordered from Sigma-Aldrich or Fischer Scientific. Oligonucleotides 
were supplied by Alta Biosciences, University of Birmingham. Restriction endonucleases, Calf alkaline 
phosphatase and Phusion® High-Fidelity DNA Polymerase were supplied by New England Biolabs. T4 DNA 
ligase was supplied by Invitrogen. dNTP was supplied by Bioline. All enzymes were used as according to 
manufacturer’s instructions and with supplied buffers.   
 
2.2 Buffers, Solutions and Reagents 
Solutions for use with bacterial or DNA manipulation were autoclaved prior to use for 20 minutes at 120ᴼC and 
15 psi or filter sterilised using a Acrodisc 32 mm syringe filter with 0.2 µm supor® membrane (PALL). 
 
2.2.1 Gel Electrophoresis of DNA 
General 
DNA loading dye:  5X DNA loading buffer (Bioline) 
WebGreen DNA Stain:  2-5 µL per 100mL 0.8-3.0% agarose solution (Web Scientific) 
DNA markers:   100 bp and hyperladder 1 (Bioline) 
 
Agarose gel electrophoresis 
50x TAE buffer:  2 M Tris acetate, 100 mM Na2EDTA. Diluted to 1x for use as running buffer 
Agarose solutions:  0.8-1.2% agarose in 1X TAE, 800 Watt in a microwave until dissolved 
 
Polyacrylamide gel electrophoresis 
5x TBE buffer:  0.335M Tris borate pH8.3, 10mM Na2EDTA (National Diagnostics). Diluted to 1x 
for use as running buffer 
Stock acrylamide:  30% (w/v) acrylamide, 0.8% bisacrylamide stock solution (Protégél - National 
Diagnostics)  
7.5% acrylamide:  125 mL stock acrylamide solution, 100mL 5x TBE, 20ml glycerol, 255ml distilled 
water 
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2.2.2    Extraction and Purification of Nucleic Acids 
Phenol/Chloroform:  phenol/chloroform/isoamyl alcohol (25/24/1 v/v), pH 8.0 (Sigma) 
TE buffer:  10 mM Tris pH 8.0, 0.5 mM EDTA 
 
2.2.3    β-galactosidase Assays 
Z-buffer:  0.75 g/L KCl, 0.25 g/L MgSO4.7H20, 8.53 g/L Na2PO4, 4.87 g/L NaH2PO4.2H2O, 
2.70 ml/L β-mercaptoethanol (β-mercaptoethanol added after autoclaves, immediately 
prior to use) 
ONPG:    o-nitrophenyl-β-D-galactopyranoside 0.8 g/L (dissolved in Z buffer)  
Sodium Carbonate:  1 M Na2CO3 
 
2.2.3 Preparing Competent Cell by Rubidium Chloride Method 
TFB1:  12.1 g/L RbCl, 9.9 g/L MnCl2.4H2O, 2.9 g/L CH3CO2K, 1.1 g/L CaCl2, 1.5% (v/v) 
glycerol (Filter sterilise, keep at 4 degrees) 
TFB2:  10 mM MOPS, 75 mM CaCl2, 10 mM RbCl2, 15 % (v/v) glycerol, pH to 6.5 (Filter 
sterilise, keep at 4 degrees) 
 
2.3 Bacterial Growth Media 
2.3.1 Liquid media  
Liquid media is prepared by central services, The University of Birmingham. It is prepared with distilled water 
and autoclaved for 20 minutes at 120ᴼC and 15 psi. 
LB:    10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl 
 
2.3.2 Solid media 
Solid media is prepared by central services, The University of Birmingham. It is prepared with distilled water 
and autoclaved for 20 minutes at 120ᴼC and 15 psi. When required for use, media was heated at 100ᴼC until 
melted and left to cool to 40-50ᴼC before addition of antibiotics (section 2.3.3). Media is poured into petri dishes 
aseptically, and store at 4ᴼC.  
LB:    10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 10 g/L agar 
Lactose MacConkey:  50 g/L MacConkey lactose agar (OXOID)    
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2.3.3 Antibiotics  
Antibiotics were prepared as stated and then filter sterilised through an Acrodisc syringe filter. 
Ampicillin:   50 mg/mL in sterile distilled water (stored -20ᴼC) 
Tetracycline:   100 mg/mL in methanol (stored -20ᴼC) 
Kanamycin:   50 mg/mL in sterile distilled water (stored -20ᴼC) 
Antibiotics were added to media after autoclaving to select for plasmid/chromosomally encoded antibiotic 
resistance, at final concentrations; ampicillin 50 µg/mL, tetracycline 100 µg/mL, kanamycin 50 µg/mL. 
 
2.4 Bacterial Strains 
Bacterial strains used within this study are listed in Table 2.1. All strains used are stored at -80ᴼC as glycerol 
stocks. Before use these were re-streaked on LB agar and grown at 37ᴼC overnight. Overnight cultures were 
grown from a single colony, in 5-10 mL of LB and antibiotic supplemented were appropriate, and aerated at 
37ᴼC for 14-16 hrs. Monitoring the levels of growth of cultures were accessed by measuring the OD at 600 nm 
using a spectrophotometer (Ultraspec 2100 pro).    
 
2.5 Plasmids 
Plasmids used within this study are listed in Table 2.2. Plasmid maps are shown Figure 2.1-2.2. 
 
2.6 Gel Electrophoresis of DNA 
2.6.1 Agarose Gel Electrophoresis of DNA 
Agarose gels were used to analysis DNA fragments >500 bp. Molten agarose solution (0.8-1.2%) was cooled to 
around 60ᴼC, at which point WebGreen, which associates with DNA and fluoresces allowing visualiation of 
DNA, was added and the solution poured into a gel casting plate, up to final concentration of 0.01x. DNA 
fragments were mixed with 5:1 DNA loading dye and loaded into gels. Samples were run in 1X TAE running 
buffer at 105 V for 45 minutes against a DNA ladder. 
 
2.6.2 Polyacrylamide Gel Electrophoresis of DNA 
Polyacrylamide gels were used to analyse DNA fragments smaller than 1 Kbp. 7.5% polyacrylamide solution 
was polymerised by the addition of 0.001 volumes of TEMED and 0.01 volumes of 10% (w/v) ammonium 
persulphate, and immediately pipetted into a gel casting plate. DNA fragments were mixed with 0.2 volumes of 
DNA loading dye and loaded into gels. Samples were run in 1X TBE running buffer at 125 V for 90 minutes  
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Table 2.1: Escherichia coli K12 strains used in this study 
Strain Description Source 
 
RLG221 
 
recA56 araD139 Δ(ara-leu)7697 lacX74 galU galK hsdR strA 
 
R.Gourse 
University of 
Wisconsin-Madison 
BW25113 lacI
q
 rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78 (Baba et al. 2006) 
BW25113 
crp::aph 
ΔrhaBADLD78 crp::aph (Baba et al. 2006) 
BW25113 
fis::aph 
ΔrhaBADLD78 fis::aph (Baba et al. 2006) 
 
Table 2.2: Plasmids used in this study 
Strain Description Source 
 
pRW50 
 
Low copy number, broad host range, lac expression vector. EcoRI-
HindIII flanked promoter fragments are inserted into a region 
upstream of lacZYA, oriV (Tet
R
) (Figure 2.1) 
 
(Lodge et al. 1992) 
pSR High copy number, pBR322 derivative. EcoRI –HindIII fragments 
upstream of λoop terminator (AmpR) (Figure 2.2) 
(Kolb et al. 1995) 
 
pREIIα (and 
derivatives) 
 
Plasmid containing rpoA, expressing RNAP α subunit (derivatives 
containing alanine substitutions at positions 273-329)  
 
(Blatter et al. 1994; 
Gaal et al. 1996; 
Wood et al. 1997)  
pHTfIα (and 
derivatives) 
Plasmid containing rpoA, expressing RNAP α subunit (derivatives 
containing alanine substitutions at positions 255-271) 
(Tang et al. 1994; 
Gaal et al. 1996) 
 
pKK223-3 (and 
derivatives) 
 
Plasmid is an expression vector that encodes and expresses Fis from a 
non-native promoter (derivatives containing nucleotide substitution 
of fis, causing amino acid substitutions at positions 71 or 72) 
 
(McLeod et al. 
1999) 
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Figure 2.1: pRW50 
EcoRI-HindIII fragments are cloned upstream of trpBA replacing pUC9 linker, placing the expression of the lac 
operon under the control of the promoter on the EcoRI-HindIII fragment. pRW50 also contains the tetracycline 
resistance gene (Tet
R
), origin of replication, genes responsible for plasmid replication (trfA and trfB) and trpBA 
which is part of the lac operon. 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: pSR 
EcoRI-HindIII fragments are cloned upstream of λoop terminator. pSR allow the measurement of in vitro 
transcription from the EcoRI-HindIII fragment; transcription terminating at the λoop terminator, producing a 
transcript of a defined length. RNA1 transcribes a control transcript. pSR also contains the bla gene providing 
ampicillin resistance and the origin of replication (ori).  
r 
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against a DNA ladder and stained through 5-10 minutes incubation with 0.01x WebGreen solution. Fragments 
were visualised used a UV transilluminator. 
 
2.7 Extraction and Purification of Nucleic Acids 
2.7.1 Phenol/Chloroform Extraction of DNA 
To remove contaminating protein, DNA solutions were mixed 1:1 with Phenol/chloloform, vortexed and 
centrifuged for 2 minutes at 13,000 rpm. The top aqueous phase was transferred into a fresh microfuge tube and 
concentrated by ethanol precipitation (section 2.7.2).  
 
2.7.2 Ethanol Precipitation of DNA 
Ethanol precipitation was used to concentrate DNA and remove previous buffers. 1/10 volumes of 3 M sodium 
acetate pH 5.2, and 2 volumes of ice-cold 100% ethanol were added to DNA solution. The sample was then 
incubated overnight (14-16 hours) at -80ᴼC. After this period the sample was centrifuged at 14000 rpm and 4ᴼC 
for 15 minutes. The supernatant was decanted and 1 mL ice-cold 70% ethanol was added and centrifuged as 
before. The supernatant again was decanted and 1 mL ice-cold 100% ethanol was added and centrifuged as 
before.  The supernatant was decanted and the DNA pellet dried under vacuum for 10 minutes. The pellet was 
re-suspended in sterile distilled water.  
 
2.7.3 Purification of DNA using QIAquick PCR Purification Kit 
Purification of DNA fragment post PCR or restriction digest was performed using the QIAquick PCR 
Purification Kit (QIAGEN) following the manufacturer’s instructions. The DNA is applied to a silica membrane 
to which the fragment, >100 bp, bind. The membrane is washed with two rounds of PE buffers, which are passed 
across the membrane by centrifugation, removing primers, nucleotides, enzymes, salts and other impurities from 
DNA samples. The DNA fragments were eluted by with 50 µL of low-salt elution buffer EB, which dissociates 
the fragments from the membrane (QIAGEN).  
 
2.7.4 Electroelution of DNA from Polyacrylamide Gels 
After Polyacrylamide Gel Electrophoresis of DNA fragments (section 2.7.1), the required DNA bands were 
excised from the gel and placed into 6.0 mm dialysis tubing with 200 µL 0.1X TBE and sealed with clips. The 
tubing was placed in an electroelution tank and run at 30 mA for 30 minutes. The DNA solution from the tubing 
was transferred to a microfuge tube. 200 µL sterilised distilled water was used to wash the interior of the dialysis 
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tubing before being combined with the DNA solution. The DNA solution was then purified using Phenol/ 
Chloroform extraction (section 2.7.1) and ethanol precipitation (section 2.7.2). 
 
2.7.5 Small-Scale Preparation of Plasmid DNA (“mini-prep”) 
A culture containing the plasmid to be purified was grown overnight in LB, supplemented with any required 
antibiotic. 10 mL of culture (low copy plasmids) or 5 mL culture (high copy plasmid) was used to extract 
plasmid DNA, performed using the QIAprep Spin Miniprep Kit (QIAGEN) following the manufacturer’s 
instructions.  The culture is lysed and the lysate is separated from the suspended cell debris by centrifugation. 
The clear lysate is then loaded on the silica membrane of the spin kit, which binds the DNA. To avoid 
extraneous endonuclease activity acting on the plasmid DNA 0.5 mL Buffer PB was applied across the 
membrane filtration assisted by centrifugation. Other Impurities such as salt, enzymes and chromosomal DNA 
are washed away by two rounds of PE buffer which are run across the membrane. DNA was eluted in a small 
volume of elution buffer, which releases the DNA by altering the ionic conditions within the silica membrane.  
DNA was eluted with 50 µL elution buffer EB (QIAGEN).  
 
2.7.6 Large-Scale Preparation of Plasmid DNA (“maxi-prep”) 
A culture containing the plasmid to be purified was grown overnight in LB, supplemented with any required 
antibiotic. 500 mL culture was used to extract plasmid DNA, performed using the QIAprep Spin Maxiprep Kit 
(QIAGEN) following the manufacturer’s instructions. The principles of DNA purification are the same as those 
describes in section 2.7.5 but on a larger scale. Plasmid DNA was eluted with 2.0 mL TE (QIAGEN).  
 
2.8 Bacterial Transformations 
2.8.1 Preparation of Competent Cells Using Rubidium Chloride Method 
50 mL LB was inoculated with 0.5 mL of an overnight culture of the strain to be transformed and grown at 37ᴼC 
under aeration until OD650 0.4-0.6 (mid-exponential phase). The culture was then transferred to a sterile 50 mL 
centrifuge tube incubated in ice for 5-10 minutes, and then centrifuged at 4,000 rpm and 4ᴼC for 15 minutes. The 
supernatant is discarded and the pellet is resuspended in TFB1 buffer and incubated in ice for 90 minutes. The 
solution was then centrifuged at 4,000 rpm and 4ᴼC for 15 minutes, the supernatant discarded and the pellet 
resuspended in 1 mL of TFB2 buffer, this solution was transferred to microfuge tubes as 200 µL aliquots and 
stored at -80ᴼC. 
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2.8.2 Transformation of Competent Cells with Plasmid DNA 
50 µL of competent cells were mixed with 5 µL of plasmid DNA and incubated in ice for 30 minutes. The cells 
were then shocked at 42ᴼC for 45 seconds. 500 mL of LB was added to the cells, which were allowed to recover 
at 37ᴼC with aeration for 60 minutes. The cells were centrifuged at 4,000 rpm for 15 minutes, and the pellets 
were resuspended in minimal supernatant (around 80 µL) and plated on to agar supplemented with required 
antibiotics, and grown overnight at 37ᴼC. 
 
2.9 DNA Manipulations 
2.9.1 Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) was done using Phusion® High-Fidelity DNA Polymerase (New England 
Biolabs) and supplied HF buffer. The 4 µL of template (plasmid/PCR product) was added directly from the 50 
µL elute of QIAprep Spin Miniprep Kit (QIAGEN) or QIAquick PCR Purification Kit (QIAGEN). dNTP 
(Bioline) was added, with a final concentration of 1 mM (0.25 mM of each). Oligonucleotides primers (Alta 
Biosciences) (Table 2.3) were added at a final concentration of 0.75 mM each. The typical PCR cycle used is 
shown in Table 2.4.   
 
2.9.2 Restriction Digestion of DNA 
38 µL DNA solution from the 50 µL elute of QIAprep Spin Miniprep Kit (QIAGEN) or QIAquick PCR 
Purification Kit (QIAGEN) was double digested with 3 µL of each enzyme and 10 µL of appropriate buffer, 
determined using New England Biolabs online Tm calculator (http://www.neb.com/nebecomm/DoubleDigest 
Calculator.asp?). This solution was incubated at 37ᴼC for 3 hours. Plasmid DNA that was to be used as a vector 
in cloning was then treated with 3 µL calf alkaline phosphatase (New England Biolabs) and incubated at 37ᴼC 
for 3 hours to remove terminal 5’ phosphate groups. The digest was purified by Phenol/Chloroform extraction 
(section 2.7.1) or by using QIAquick PCR Purification Kit (QIAGEN) (section 2.7.3).     
 
2.9.3 DNA Ligations  
10 µL of restriction digested insertion DNA, 5 µL restriction digested, dephosphorylated vector DNA, 1 µL T4 
DNA ligase and 2 µL T4 DNA ligase buffer were mixed and incubated at room temperature for 3 hours. This 
ligate mixture was added to 50 µL RLG221 competent cells as described (section 2.8.2). When transforming into 
pRW50 vector, the cells were plated on MacConkey agar, allowing red/white screening of overnight 
transformants for candidates. Red colonies were selected and grown overnight to extract plasmids using QIAprep 
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Spin Miniprep Kit (QIAGEN) (section 2.7.5). Plasmids were screened by PCR, using primers flanking the 
insertion sites on the plasmid. Positive candidates were sequenced using the appropriate primer (section 2.9.4).    
 
2.9.4 DNA Sequencing  
Plasmid-to-profile sequencing was performed by the Function Genomics and Proteomics Laboratory, University 
of Birmingham. 5 µL of plasmid was mixed with 3 µL 1 mM sequencing primer up to 10 µL in sterile distilled 
water. The sequencing primers are listed in Table 2.3. 
 
2.9.5 Introduction of Point Mutations Using Megaprimer PCR 
In the first round of PCR the template EcoRI-HindIII fragment was present in pSR vector. The point mutation is 
inserted through a mutagenic primer and flanking primer, Psr_R (Table 2.3). The fragment was purified by 
QIAquick PCR purification kit was eluted in 30 µL of EB buffer. The second round of PCR was performed with 
the previous template but this time with 10 µL of the purified megaprimer and the alternate flanking primer 
D5431. This produced the full length EcoRI-HindIII fragment with the required mutation. This fragment was 
purified by QIAquick PCR purification kit, double digested by EcoRI and HindIII, and cloned into pRW50 
and/or pSR (section 2.10). Mutagenic primers are listed in Table 2.3 and resultant EcoRI-HindIII fragment listed 
in Table 2.5. 
 
2.10 Cloning of Promoter Fragments into pSR and pRW50 
2.10.1 Preparation of EcoRI-HindIII Promoter Fragments by PCR 
All the promoter fragments used in this study are listed in Table 2.5 and their sequences shown Figures 2.4 -2.22. 
aer1 and derivatives where created from pSR aer1 by megaprimer PCR (Section 2.9.5), using primers D5431 
and Psr_R and the relevant mutagenic primer (Table 2.3). FnCC(-40.5) and derivatives (F45CC(-40.5), F40CC(-
40.5), F35CC(-40.5), F30CC(-40.5), F25CC(-40.5), F15CC(-40.5)) were created using megaprimer PCR from pSR 
F35CC(-40.5) using primers D5431 and Psr_R and the relevant mutagenic primer (Table 2.3). F24CC(-40.5) and 
F26CC(-40.5) were created from pSR F25pCC(-40.5) D5431 and Psr_R and the relevant mutagenic primer (Table 
2.3). Fc66F25CC(-40.5) was created from pRW50 F35CC(-40.5) using PCR and the primers F2CCcons and 
D10527.  
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Table 2.3: Oligonucleotides Primers Used In This Study  
 Name Sequence (5’→3’) Use 
S
eq
u
en
ci
n
g
 
 
D10520 
 
CCCTGCGGTGCCCCTCAAG 
 
Anneals upstream of EcoRI in pRW50. 
Sequencing and amplification of insert. 
D10527 GCAGGTCGTTGAACTGAGCCT
GAAATTCAGG 
Anneals downstream of HindIII in pRW50. 
Sequencing and amplification of insert. 
D5431 ACCTGACGTCTAAGAAACC Anneals upstream of EcoRI in pSR. 
Sequencing and amplification of insert. 
Psr_R GACGACGACATGGCTCGATTG Anneals downstream of HindIII in pSR. 
Sequencing and amplification of insert. 
M
u
ta
g
en
ic
 
 
F15CC(-40.5) 
 
GGAGAGCTCATGTGATGTACA
TCACATGG 
 
Deletes 20 nt between fisI site and CRP site of F35pCC(-
40.5) 
F24CC(-40.5) GGAGAGCTCATCAGGTAAAT
G 
Deletes 11 nt between fisI site and CRP site of F35pCC(-
40.5) 
F25CC(-40.5) GGAGAGCTCGATCAGGTAAA
TG 
Deletes 10 nt between fisI site and CRP site of F35pCC(-
40.5) 
F26CC(-40.5) GGAGAGCTCCGATCAGGTAA
ATG 
Deletes 11 nt between fisI site and CRP site of F35pCC(-
40.5) 
F30CC(-40.5) GGAGAGCTCCCGGGGATCAG
GTA 
Deletes 5 nt between fisI site and CRP site of F35pCC(-
40.5) 
F35CC(-40.5) GGAGAATTCAAAAATGATTA
ATTTATGATCAATCATTGCTC
GGTACCCGGGG 
Inserts fisI binding site of aer1 upstream of CC(-40.5) 
centred at position -91 in regards to transcription start 
site 
 
 
28 
 
F39CC(-40.5) GGAGAGCTCCATGGGTACCCG
GGGATC 
Inserts 4 nt between fisI site and CRP site of F35pCC(-
40.5) 
F40CC(-40.5) GGAGAGCTCCATGGGGTACCC
GGGGATC 
Inserts 5 nt between fisI site and CRP site of F35pCC(-
40.5) 
F41CC(-40.5) GGAGAGCTCCATGGAGGTAC
CCGGGGATC 
Inserts 6 nt between fisI site and CRP site of F35pCC(-
40.5) 
F45CC(-40.5) GGAGAGCTCCATGGATATCGG
TACCCGGGGATC 
Inserts 10 nt between fisI site and CRP site of F35pCC(-
40.5) 
F2CCcons GGAGAATTCATAATGGATCAA
ATTTTGAGCAAAAAAAAACA
AAAATGATTAATTTATGATC 
Inserts 37 nt of aer1 sequence upstream of F35pCC(-
40.5), includes fisII site which is altered to the 
consensus Fis binding site sequence 
PetFISIIC GGAACCTGATAATGCTCCTAA
ATAGGAGCAAAAAAAAC 
2 nt substitution in fisII site of aer1 which is unable to 
recruit Fis   
aer1_5 CAATCAGCATTGGTTGACATC
GTATCA 
5 nt deletion between -10 element and crp site, in aer1 
aer1_10 CAATCAGCATTGGTTCGTATC
ATTAAC 
10 nt deletion between -10 element and crp site, in aer1 
Pet_R GGGAAGCTTGTATTTTATTCA
TATATTCTCTCAACTCATTTAT
TG 
Anneals downstream of pet promoter and inserts a 
HindIII site  
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Table 2.4: PCR Cycle 
 
 
 
 
 
 
 
The annealing temperature required for the PCR reaction was determined using New England Biolabs online Tm 
calculator (http://www.neb.com/nebecomm/tech_reference/TmCalc/ Default.asp?). The extension time was for 
the expected PCR product was determined by the manufacturer’s instructions (15–30 seconds per kb). 
  
Cycle step Cycles Temp Time 
 
Initial Denaturation 
 
1 
 
98°C 
 
30 seconds 
Denaturation 
Annealing 
Extension 
30 
98°C 
45–72°C 
72°C 
5–10 seconds 
10–30 seconds 
15–30 seconds per kb 
 
Final extension 
 
1 
 
72°C 
 
5–10 minutes 
Hold 1 4°C ∞ 
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Figure 2.3: Megaprimer PCR 
The megaprimer is generated in the First PCR reaction using a primer flanking the fragment (primer 1) and a 
mutagenic primer (primer 2). The PCR product is used in the second reaction to generate the full mutagenic 
fragment using the megaprimer and a primer that flanks the opposite side of the fragment (primer 3). This is then 
digested with restrictive enzymes and ligated in to an appropriate vector.  
  
QIAquick PCR 
purification kit 
QIAquick PCR 
purification kit 
Megaprimer 
X 
X 
X 
X 
X 
X 
First PCR Reaction 
Second PCR Reaction 
Primer 1 
Primer 2 
Primer 3 
Site1 Site2 
Restriction 
enzymes 1 and 2 
X 
X 
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2.10.2 Construction of aer1 and FnCC(-40.5) derivatives  
Derivatives of aer1 and FnCC(-40.5) were prepared from pSR aer1 and pSR FnCC(-40.5). pSR was extracted by 
QIAspin miniprep kit, double digested with EcoRI and HindIII and treated with calf alkaline phosphatase, and 
purified by phenol/chloroform purification followed by ethanol. EcoRI-HindIII fragments (section 2.10.1) (Table 
2.5) were inserted into pSR by ligation for 3 hours at room temperature, and this ligate was transformed in 
rubidium chloride treated RLG221 competent cells. These cells were selected for by overnight growth on an 
Ampicillin supplemented LB agar plate. Candidates were verified by sequencing using primers D5431 and/or 
Psr_R. Successful candidates were grown overnight and plasmids extracted by QIAspin miniprep kit, double 
digested with EcoRI and HindIII and treated with calf alkaline phosphatase, and purified by phenol/Chloroform 
purification followed by ethanol. pRW50 was extracted by QIAspin miniprep kit, double digested with EcoRI 
and HindIII and treated with calf alkaline phosphatase, and purified by phenol/Chloroform purification followed 
by ethanol precipitation. EcoRI-HindIII fragments were inserted into pRW50 by ligation for 3 hours at room 
temperature, and this ligate was transformed in Rubidium Chloride treated RLG221 competent cells. These cells 
were selected for by overnight growth on a tetracycline supplemented MacConkey agar plate. Candidates were 
selected by red coloured colonies and verified by sequencing using primers D10520 and/or D10527.  
 
2.12 β-galactosidase Assays  
β-galactosidase assays were used to measure the activities of a plasmid encoded promoter:lacZ fusions in several 
genetic backgrounds (Miller, 1972). 5 mL of LB was supplemented with appropriate antibiotics and inoculated 
with a freshly transformed colony, containing pRW50 with the promoter of interest, and incubated overnight at 
37°C. The following day, 5 mL LB was inoculated with the overnight culture at a 1:100 dilution for 
measurements of β-galactosidase activity during aerobic growth. Once cells had reached the required OD650=0.5, 
they were immediately placed on ice and the exact OD600 reading was recorded. To lyse cells, 2 mL samples 
were added to 30 µL toluene and 30 µL 0.1% sodium deoxycholate and incubated for 30 min at 37°C, with 
aeration. For measurements of β-galactosidase activity, 100 µLof cell lysate was added to 2 ml Z buffer (0.75 
g/L KCl, 0.25 g/L MgSO4.7H2O, 8.53 g/L Na2HPO4, 4.87 g/L NaH2PO4.2H20); β-mercaptoethanol was added to 
Z buffer prior to use, at 0.27 mL per 100 mL Z buffer. The assay was initiated by the addition of 0.5 ml o-
nitrophenyl-β-D-galactopyranoside (ONPG) solution, dissolved in Z buffer (3.92 g/L). Once the solution had 
changed from a clear colour to a straw yellow colour or 1 h had elapsed, 1 mL 1 M sodium carbonate was added 
to stop the reaction and the reaction time recorded. The absorbance at 420 nm of the resultant solution was 
measured and the calculation of β-galactosidase activity was calculated as follows:   
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β-galactosidase activity =   1000 x 2.5 x 3.6 x OD420      nmol/min/mg bacterial mass 
              OD650 x 4.5 x t x v 
Where:                              
2.5   =  factor for conversion of OD650 into bacterial 
mass, based on OD650 of 1.0 being equivalent 
to 0.4 mg/mL bacteria (dry weight).  
3.6   =  final assay volume (mL) 
1000
/4  =  factor for conversion of OD420 into nmol o-
nitrophenyl (ONP), based on 1nmol mL
-1 
ONP having an OD420 of 0.0045 
t     =  incubation time (min) 
v    =  volume of lysate added (in mL)  
 
Each experiment was done in triplicate and the mean and standard deviation calculated accordingly.
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Table 2.5: EcoRI-HindII fragments used in this study 
Name Description Source 
   
aer1 -275 to +89 in respects to the transcription start site of the Pet promoter 
(EAEC strain 042) 
(Rossiter et al. 2011)* 
aer1-fisI Derivative of aer1 with G at position -84 and C at position -98  (Rossiter et al. 2011)* 
aer1-fisII Derivative of aer1 with G at position -119 and C at position -126 (Rossiter et al. 2011)* 
aer1-fisI/II Derivative of aer1 with G at positions -84 and -119 and C at positions -
98 and -126 
This study 
aer1 Δ5 aer1 with 5 bp deleted between -10 element and crp site This study 
aer1 Δ10 aer1 with 10 bp deleted between -10 element and crp site This study 
 
 
CC(-41.5) 
 
E. coli melR promoter derivative with consensus DNA site for CRP 
centred at –41.5 
 
(Gaston et al. 1990)* 
CC(-40.5) CC(-41.5) with 1 bp deleted between -10 element and crp site (West et al. 1993)* 
F15CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -71 This study 
F24CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -80 This study 
F25CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -81 (Rossiter et al. 2011)* 
F26CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -82 This study 
F30CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -86 (Rossiter et al. 2011)* 
F35CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -91 (Rossiter et al. 2011)* 
F39CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -95 This study 
F40CC(-40.5) Derivative of CC(-40.5) with fisI of aer1 centred at position -96 (Rossiter et al. 2011)* 
F41CC(-40.5) 
F45CC(-40.5) 
Derivative of CC(-40.5) with fisI of aer1 centred at position -97 
 Derivative of CC(-40.5) with fisI of aer1 centred at position -101 
This study 
(Rossiter et al. 2011)* 
 
 
* Promoters were kindly provided by Henderson and Busby labs 
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Figure 2.4: aer1 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCGTAAATATGAGCAAAAAAAA 
ACAAAAATGATTAATTTATGATCAATCAGCATTGGTTTACATGACATCGTATCATTAACGAGAGCATTGTCACAC 
ATTAACAATATAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCC 
TTTGTTCATTCAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
 
Figure 2.5: aer1 -fisI 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCGTAAATATGAGCAAAAAAAA 
ACAAAAATCATTAATTTATGATGAATCAGCATTGGTTTACATGACATCGTATCATTAACGAGAGCATTGTCACAC 
ATTAACAATATAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCC 
TTTGTTCATTCAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
 
Figure 2.6: aer1 -fisII 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCCTAAATAGGAGCAAAAAAAA 
ACAAAAATGATTAATTTATGATCAATCAGCATTGGTTTACATGACATCGTATCATTAACGAGAGCATTGTCACAC 
ATTAACAATATAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCC 
TTTGTTCATTCAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
 
Figure 2.7: aer1 –fisI/II 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCCTAAATAGGAGCAAAAAAAA 
ACAAAAATCATTAATTTATGATGAATCAGCATTGGTTTACATGACATCGTATCATTAACGAGAGCATTGTCACAC 
ATTAACAATATAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCC 
TTTGTTCATTCAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
 
Figure 2.8: aer1 Δ5 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCGTAAATATGAGCAAAAAAAA 
ACAAAAATGATTAATTTATGATCAATCAGCATTGGTTTACATCGTATCATTAACGAGAGCATTGTCACACATTAA
CAATATAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCCTTTGT
TCATTCAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
 
Figure 2.9: aer1 Δ10 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCGTAAATATGAGCAAAAAAAA 
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ACAAAAATGATTAATTTATGATCAATCAGCATTGGTTCGTATCATTAACGAGAGCATTGTCACACATTAACAATA
TAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCCTTTGTTCATT
CAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
 
Figure 2.10: CC(-41.5) 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAAGTGATGTACATCACATGGATCCCCCTCACTCCTGCCATAATT
CTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
 
Figure 2.11: CC(-40.5) 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAAGTGATGTACATCACATGGATCCCCTCACTCCTGCCATAATTC
TGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
 
Figure 2.12: F15CC(-40.5)             
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCATGTGATGTACATCACATGGATCCCCTCACTCCT
GCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
      
Figure 2.13: F24CC(-40.5) 
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCATCAGGTAAATGTGATGTACATCACATGGATCCC
CTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT      
 
Figure 2.14: F25CC(-40.5)  
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCGATCAGGTAAATGTGATGTACATCACATGGATCC
CCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
 
Figure 2.15: F26CC(-40.5)             
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCGATCAGGTAAATGTGATGTACATCACATGGATC
CCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
 
Figure 2.16: F30CC(-40.5) 
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCCGGGGATCAGGTAAATGTGATGTACATCACATG
GATCCCCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
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Figure 2.17: F35CC(-40.5)            
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCGGTACCCGGGGATCAGGTAAATGTGATGTACATC
ACATGGATCCCCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCT
T 
 
Figure 2.18: F39CC(-40.5)              
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCATGGGTACCCGGGGATCAGGTAAATGTGATGTA
CATCACATGGATCCCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAA
GCTT 
 
Figure 2.19: F40CC(-40.5)              
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCATGGGGTACCCGGGGATCAGGTAAATGTGATGT
ACATCACATGGATCCCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAA
AGCTT 
 
Figure 2.20: F41CC(-40.5)                  
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCATGGAGGTACCCGGGGATCAGGTAAATGTGATG
TACATCACATGGATCCCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATA
AAGCTT 
 
Figure 2.21: F45CC(-40.5) 
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCATGGATATCGGTACCCGGGGATCAGGTAAATGT
GATGTACATCACATGGATCCCCTCACTCCTGCCATAATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACA
GATAAAGCTT 
 
Figure 2.22: Fc66F35CC(-40.5) 
GAACCTGATAATGCTCGTAAATATGAGCAAAAAAAAACAAAAATGATTAATTTATGATCAATCATTCGAGCTCC 
ATGGATATCGGTACCCGGGGATCAGGTAAATGTGATGTACATCACATGGATCCCCTCACTCCTGCCATAATTCT 
GATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
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Chapter 3 
Regulatory Region of the Pet Operon 
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3.1 Introduction 
The pet gene is present on the pAA plasmid of EAEC strain 042 and encodes a serine protease autotransporter, 
Pet. As determine by prior work by Rossiter et a.l 2011, the transcription activation of pet is CRP dependant; 
where CRP binds and interacts with RNAP from its site centred at -40.5, with respect to transcription start site. 
Two Fis binding sites reside upstream of the CRP binding site; CRP dependant activation is enhanced by the 
presence of the downstream Fis DNA binding site (fisI; centred -91) but the presence of the upstream Fis DNA 
binding site (fisII; centred -122) appears to be repressive. Fis is shown to bind the fisI and fisII sites in vitro, but 
the mechanism by which enhancement and repression occurs is still undefined. The following work has the aim 
of firstly, confirming the face of helix dependence of the fisI site within the pet promoter and secondly, 
examining the mechanism of repression occurring due to the presence of the fisII site. The following 
experiments utilised aer1 and related derivatives, which contained the regulatory region of the pet gene, to 
further elucidate the actions of Fis at the pet promoter.  
 
3.2  Spatial Constrains of Fis Activation  
The Fis site is known to activate transcription when bound to the fisI binding site, through an undetermined 
mechanism (Rossiter et al. 2011). A number of derivatives of the pet promoter were created to assess the spatial 
constraints on the synergistic activation by Fis and CRP, providing insights regarding the mechanisms involved. 
These constructs where constructed from aer1 (Sequence -275 to +89; in respects to the transcription start site of 
the pet promoter of EAEC strain 042). Either 5 nt (aer1 Δ5) or 10 nt (aer1 Δ10) were deleted from within the 
region between the fisI and crp sites altering the orientation of the fisI site on the DNA helix; to either the 
opposite side of the helix (aer1 Δ5) or the original side of the helix, albeit closer to the crp site (aer1 Δ10). When 
the activities of these promoters were assessed the level of expression from the aer1 and aer1 Δ10 were the same, 
whilst the levels of aer1 Δ5 were significantly reduced (Figure 3.2). These results show the enhancement of the 
fisI is face-of-helix dependant, with activation only occurring when the fisI site was position on the same face of 
the DNA helix as the crp site.  
 
3.3 Contributions of Fis DNA Binding Sites to Expression 
When Fis binds the pet promoter it either activates transcription, bound to the fisI binding site, or represses 
transcription bound to the fisII. To assess the contribution of each of the Fis binding sites upon the expression 
from the pet promoter, several derivatives containing nucleotide substitutions were created (Rossiter et al. 2011).  
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                              -170                  -160                      -150                       -140                   -130                                                   -110 
           ·         ·         ·         ·         ·         ·         · 
GAATTCTTCCATGTGACATCTCAGATGGAAGCTCAGATGGAACCTGATAATGCTCGTAAATATGAGCAAAAAAAA 
EcoR1           fisII 
          (-122) 
               -100                    -90                       -80                         -70                   -60                         -50                         -40 
      ·         ·         ·         ·         ·         ·         · 
ACAAAAATGATTAATTTATGATCAATCAGCATTGGTTTACATGACATCGTATCATTAACGAGAGCATTGTCACAC    
             fisI          crp 
                              (-91)            (-40.5) 
 -30                         -20                        -10 
 ·        ·         ·  
ATTAACAATATAGAACTGTTACTTTTTACGGGATATTAGTAACAAACCATTACTAATGGTTTTAATTCTTAATCC 
    +1 
 
 
TTTGTTCATTCAATAAATGAGTTGAGAGAATATATGAATAAAATATACAAGCTT 
         HindIII 
 
 
 
Figure 3.1: Point Mutations and Deletions Within the aer1 Fragment 
The sequence of the aer1, which contains the pet regulatory region and downstream sequence, including the 
translational start site AUG (underlined). The transcription factor binding regions are underlined and labelled 
with the sites name and positions in regards to the transcription start side (+1). The vertical arrows identify the 
bases which were substituted for the BOLD base; 2 for each site which inactive the site by reducing the 
homology of the site to the consensus transcription factor binding sequence. The double underlined text The 
substitution of nucleotides within promoter elements can reduce or increase the homology of a promoter element, 
compared to the highest affinity sequence referred to as the consensus sequence, reducing or increasing identifies 
the nested deletions; the orange text signifying the 5 nt deletion (aer1 Δ5) and the entire underlined sequence for 
the 10 nt deletion (aer1 Δ10).  
C 
C G
  C 
G
  C 
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Derivatives of aer1 were created were the Fis binding sites were altered by substituting two nucleotide bases, 
critical for factor binding, reducing the ability of the sites to recruit and bind Fis (shown in Figure 3.1). These 
derivatives had their fisI site disrupted (aer1 -fisI), fisII site disrupted (aer1 –fisII) or both fisI and fisII sites 
disrupted (Rossiter et al. 2011). First the activity observed when the fisII was disrupted showed a slightly raised 
activity when compared to aer1 (Figure 3.3). When the fisI site is disrupted the levels of expression are greatly 
diminished, although when the fisII is also disrupted this reduced activity is not seen to change (Figure 3.3). 
Suggesting the repressive action of the fisII site is dependant the presence of a functional on fisI site.      
 
3.4  Discussion 
Fis plays an important role in the positive and negative regulation of transcription at the pet promoter. The 
results obtained during this and the past study demonstrate Fis can only enhancement activation, when the Fis 
binding site is present on the on the same face of the DNA helix as the CRP binding site (Rossiter et al. 2011). 
The face of helix dependence on transcriptional activity of Fis suggests a direct interaction with RNAP may be 
present; activating transcription via a class I mechanism. Fis cannot enhance expression alone and requires the 
presence of CRP to function, due to the distance of the fisI site from the RNAP binding region. A set of Fis 
regulated promoters were assessed in regards to the locations of the DNA binding sites and the mechanism of 
regulation (Figure 3.4). Promoters that are only regulated Fis, in a class I manner, do so from sites positioned 
between a specific (Orange box Figure 3.4); -58 and -76 in regards to the transcription start site. Furthermore, 
promoters with activatory Fis binding sites positioned close to -91, as in the pet promoter, generally have a 
second, downstream transcription factor binding site. This second site has seen to be a Fis binding sites, most 
commonly positioned around -70, and a CRP binding site; one promoter possessing a downstream CRP binding 
site at -63.5 (Keseler et al. 2011). No promoters possessing the pet promoter architecture had been studied prior 
to Rossiter et al. 2011. This suggests the mechanism of transcription activation by Fis, bound around position -
91, requires the action of a downstream factor bound on the same face of the DNA helix. This requirement is 
presumably due to the DNA bending provided by the downstream factor (Fis or CRP) which facilitates 
activation by the upstream Fis. Favourable variation of DNA topology offers another possibility for fisI mediated 
enhancement where DNA bending that accompanies Fis binding confers a beneficial conformational change of 
the local downstream (Muskhelishvili and Travers 2003). Whether or not a direct interaction between the RNAP 
and upstream Fis in the pet promoter occurs is unclear, and therefore requires further investigation to determine 
the precise mechanism of activation. Mutational analysis of the promoter failed to show Fis repressing  
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Figure 3.2: Nested Deletions Within the aer1 Fragment  
A graph displaying the relative activities of constructs of aer1, containing nested deletions, when cloned into 
pRW50 and transformed into E. coli BW25113; following a β-galactosidase assay. Where aer1 Δ5 has contains a 
5 nt deletion from the spacer between the CRP and fisI site and aer1 Δ10 contains a 10 nt deletion from the same 
region. Cell were grown anaerobically at 37°C in LB broth until early log phase (OD650=0.4) and results are the 
average of three independent assays; standard deviation shown by error bars.  
 
Figure 3.3: Point Mutations Within the aer1 Fragment 
A graph displaying the relative activities of aer1constructs, containing point mutation, when cloned into pRW50 
and transformed into E. coli BW25113; following a β-galactosidase assay. Where the fisI site of aer1 has been 
disrupted (aer1 –fisI), the fisII site been disrupted (aer1 –fisII) and where both fisI and fisII sites have been 
disrupted (aer1 –fisI/II) (Rossiter et al. 2011). Cell were grown anaerobically at 37°C in LB broth until early log 
phase (OD650=0.4) and results are the average of three independent assays; standard deviation shown by error 
bars.  
Δ Δ 
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expression from the fisII site; when both the fisI and fisII were deleteriously mutated. The repressive actions of 
Fis at the fisII site must therefore dependent on the presence of a functional fisI site. Several mechanisms 
whereby fisII represses transcription, requiring a functional fisI site, are possible. (1) A direct interaction 
between Fis bound at fisII and RNAP, facilitated by the bending of the DNA by the downstream bound CRP and 
Fis, could modulate transcription by inhibiting promoter escape (Lee and Busby 2012). (2) The fisII site 
competes with fisI site for the recruitment of Fis, reducing the levels of expression by reducing the occupation of 
fisI (Lickwar et al. 2012). (3) Fis may modulate transcription by negatively altering the topology of the promoter, 
although which factors within the promoter this might affect is unclear (Schneider et al. 1999; Grainger et al. 
2008). Further investigation is required to determinate which mechanism of repression occurs.  
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Figure 3.4: Fis Regulatory Sites in E. coli K12  
This diagram shows the positions Fis DNA binding sites in regards to the transcription start site, from a database of sequenced and annotated promoters (ecocyc). Fis binding 
sites were plotted based on the position of the binding site and if it activates (+) or represses (-) gene expression (Keseler et al. 2011). The orange box shows the region, -58 
to-76, where Fis is seen to promote expression solely in a class I manner. Activating Fis site upstream of this region (-58 to -76) are seen to contain a second downstream 
transcription binding site.  
+ 
- 
Transcription start site 
Fis 
Class I region 
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Chapter 4 
Emulation of the pet Promoter Architecture in a Model Promoter 
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4.1 Introduction 
There are many questions regarding the transcription regulation of pet that still remain. The contribution of 
promoter architecture upon transcription regulation was investigated; the architecture of the pet promoter was 
emulated in a well-studied promoter (Rossiter et al. 2011). The well-studied promoter, CC(-40.5), derived from 
MelR, whose CRP binding site is centred 40.5 bp upstream of the transcription start site. The fisI site was cloned 
35 bp upstream of the CRP binding site; resulting in the promoter F35CC(-40.5) (Rossiter et al. 2011). This 
model system provided a base upon which positions of the transcription factor binding sites could be altered, 
allowing the effect of the position of these binding sites on gene expression to be assessed. This work presented 
in this chapter evaluates the mechanisms utilised by Fis in the transcription regulation of pet-like promoters, in 
terms of architecture, and probing the proposed intimate interactions between the α subunit of RNAP and Fis. 
 
4.2 Emulation of PET Promoter Architecture 
The mechanistic action of the fisII site of the pet promoter is not well defined; questions regarding how 
transcription is repressed still remain. To address this matter, a consensus Fis binding site (Fc) was cloned 66 bp 
upstream of the FisI site of F35CC(-40.5); producing Fc66F35CC(-40.5) (Figure 4.1). The addition of an upstream 
Fis binding site, stronger than that of the fisII of pet, should have the effect of causing repression equal to if not 
greater than that observed in the pet promoter. The levels of expression from the F35CC(-40.5) and Fc66F35CC(-
40.5) show no significant change, implying the addition of the upstream Fis binding site has no noticeable effect 
on expression (figure 4.2).  
 
4.3 Activity of FnCC(-40.5) Promoter Series 
Fis is able to activate transcription, directly and indirectly, via variety of mechanisms. Fis appears to activated 
transcription, bound at fisI, via a class I activation mechanism (Travers and Muskhelishvili, 1998). To probe the 
mechanism by which Fis collaborates with CRP to induce transcription, a series of promoter constructs were 
created (FnCC(-40.5) where the spacer region between the Fis and CRP binding sites was varied in length (n = 
number of bases between the centres of the Fis and CRP DNA binding site) (Figure 4.1) (Rossiter et al 2011). 
The expressions of these promoters were assessed under wild type and Δfis genetic backgrounds. Several peaks 
of expression were observed (F25CC(-40.5), F35CC(-40.5) and F45CC(-40.5)); the level of expression decreased 
as “n” increased (figure 4.3). Those promoters with n+/-1 of the F25CC(-40.5) peak (F24CC(-40.5) and F26CC(-
40.5)) were Fis dependant, but had levels of expression lower than the peak. The promoters that generated these 
three peaks of expression have fisI sites on the same face of the DNA helix as the crp site; the 
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                             * 
                                           TGGAACCTGATAATGCTCGTAAATATGAGCAAAAAAAAAC              Fc66FnCC(-40.5) 
   fis II 
       
             * 
GAATTCAAAAATGATTAATTTATGATCAATCATTCGAGCTCCATGGATATCGGTACCCGGGGATCAGGTAAATGTGATGTACATCACATGGATCCCCCTCACTCCTGCCATAAT 
EcoRI             Fis I            crp 
        (-101)           GAGCTCCATGGATATCGGTACCCGGGGATC       (-40.5)     F45CC(-40.5)* 
           GAGCTCCATGGA----GGTACCCGGGGATC      F41CC(-40.5) 
           GAGCTCCATGG-----GGTACCCGGGGATC      F40CC(-40.5)* 
     GAGCTCCATG------GGTACCCGGGGATC      F39CC(-40.5) 
           GAGCTC----------GGTACCCGGGG       F35CC(-40.5)* 
           GAGCTC---------------CCGGGGATCAGGTA        F30CC(-40.5)* 
           GAGCTCC-------------------GATCAGGTAAATG    F26CC(-40.5) 
          GAGCTC--------------------GATCAGGTAAATG     F25CC(-40.5)* 
          GAGCTC---------------------ATCAGGTAAATG    F24CC(-40.5) 
          GAGCTC------------------------------ATGTGATGTACATCACATGG  F15CC(-40.5) 
 
 
TCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT      
       +1           Hind III 
 
 
Figure 4.1: The FnCC(-40.5) series 
The sequence of the FnCC(-40.5) series with transcription factor binding regions are underlined and labelled with the sites name and positions in regards to the transcription 
start side (+1). The series differs by length of sequence located between the CRP site (-40.5) and the fisI site; where n signifies the number of bases between the centres of 
these two site. The sequence for F45CC(-40.5) is shown in black with the orange dashes (-) flanked by complementary sequences denoting the bases removed in the 
construction of each of the FnCC(-40.5) series. The construction of Fc66F35CC(-40.5) differs from the series by the addition of the red sequence from the red asterisk (*).  
* Rossiter et al. 2011
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peaks are separated by 10 bp, or one completed turn of the DNA helix. This suggests that Fis is able to induce  
transcription when correctly orientation on the same side of the DNA helix as the CRP DNA binding site. As fisI 
is moved away further from the 3 peak positions (n=25, 35 & 45) the expression is reduced until Fis does not 
induce expression, with levels reduced to that to that of CC-40.5. These results, when put together, lend credence 
to the proposed class I interaction between Fis and RNAP, but direct evidence of this interaction is still lacking. 
 
4.4  Effect of α-CTD alanine substitution mutants on the expression of the FnCC(-40.5) Series  
Transcription factors are able to modulate gene expression, particularly transcription initiation, through a number 
of mechanisms. Class I and class II activators are able to induce transcription by binding to specific sites within 
the promoter region and recruit RNAP to the promoter; through direct interactions with the carboxyl terminal 
domain of the RNAP α subunit (α-CTD). The residues of the α subunit involved in this interaction depends on 
the transcription factor involved and the position of the transcription factor binding site in the promoter. By 
substituting the interacting residues, for alanine, electrostatic interactions between the transcription factor and α-
CTD can be disrupted, reducing the transcriptions factor ability to recruit RNAP and induce transcription. By 
measuring the reduction in gene expression it is possible to measure the impact an individual amino acid on the 
overall interactions. CRP interacts with positions 271 and 273 of the α subunit when acting as a class II activator 
and Fis interacts with positions 271, 285 and 287 of the α subunit as class I activator (Savery et al. 1998; Aiyar 
et al. 2002). These 4 residues (271, 273, 285 and 287) and the control residue (261) were assessed across 4 
promoters (CC(-40.5), F25pCC(-40.5), F30pCC(-40.5) and F35pCC(-40.5)). The alanine substitution of residues 
285 and 287 affected all of the promoters, consistent with the activation of all of the promoters by CRP (Figure 
4.4). The alanine substitution of residue 271 reduces the expression of F30CC(-40.5) and F35CC(-40.5), and the 
alanine substitution of residue 273 affects the Fis induced promoters (F25(CC-40.5) and F35(CC-40.5)). These 
two results are consistent with the notion that promoter F25(CC-40.5) and F35(CC-40.5) are induced by a class I  
Fis mechanism. The substitution of residue 261 reduced the expression of the CC(-40.5) promoter, which was 
unexpected as this reduction was not previously seen in CC(-41.5) but may be due to the architectural  
differences between these promoters activator (Savery et al. 1998; Aiyar et al. 2002). These results require  
further proof to determine if an interaction between Fis and the α-CTD occurs.  
 
4.5 Effect of the Substitution of Critical Fis Residues on Expression of F25CC(-40.5)   
Fis is able to act as a transcriptional activator by interacting with the α-CTD through the critical residues 71 and 
72, of Fis; substitution of these residues with other amino acids is able to modulate the nature of this interaction   
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Figure 4.2: Implications of a Second Upstream Fis Binding Site 
A graph displaying the relative activities of F35CC(40.5) and Fc66F35CC(40.5) constructs when cloned into 
pRW50 and transformed into E. coli BW25113; following a β-galactosidase assay. Fcn signifies the presence a 
Fis binding site, of consensus sequence, and Fpn the fisI site from the pet promoter; where n indicates the how 
many nucleotides the centre of the Fis binding site is upstream of the centre of the downstream CRP binding site, 
centred at -40.5, in respects to the transcription start site. Cell were grown anaerobically at 37°C in LB broth 
until early log phase (OD650=0.4) and results are the average of three independent assays; standard deviation 
shown by error bars.  
Figure 4.3: Transcriptional Activity of the FnCC(-40.5) Series 
A graph displaying the relative activities of FnCC(40.5) series constructs when cloned into pRW50 and 
transformed into E. coli BW25113 or E. coli BW25113 Δfis; following a β-galactosidase assay. Cell were grown 
anaerobically at 37°C in LB broth until early log phase (OD650=0.4) and results are the average of three 
independent assays; standard deviation shown by error bars. The activities were also normalised by determining 
the average difference in β-galactosidase activity between BW25113 and BW25113 Δfis, for CC(-40.5) and 
CC(-41.5), and applying the normalisation factor to the β-galactosidase activities of subsequent constructs. 
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Figure 4.4: Impact of Alanine Substitutions Within α on FnCC(-40.5) Series  
β-galactosidase assay displaying the activities of FnCC(40.5) constructs carried by pRW50 within E. coli 
BW25113 containing either the pHTfIα (PHT) or pREIIα (PRE) plasmid(Blatter et al. 1994; Gaal et al. 1996; 
Wood et al. 1997; Tang et al. 1994; Gaal et al. 1996)); containing either WT α or α containing an alainine 
substitution at positions 261 or 271 (PHT), or 273, 285 or 287(PRE). Results are shown as a percentage of WT α 
β-galactosidase activity when in plasmid, PRE or PHT; WT α is shown as 100% and the greatest standard 
deviation of WT α is displayed as the grey shaded box. Cell were grown anaerobically at 37°C in LB broth until 
early log phase (OD650=0.4) and results are the average of three independent assays; standard deviation shown by 
bars. The bottom right cartoon represents the pet promoter with RNAP, CRP and Fis bound; residues of α that 
know determinates in the class I Fis interaction and class II CRP are indicated.  
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(Bokal et al. 1997; Cheng et al. 2000; Aiyar et al. 2002). Residue 71 is important as it contributes to an 
electrostatic interaction with the α-CTD, whilst residue 72 maintains the environment of the α-CTD contacting 
region, with the disruption of either through deleterious substitutions, able to negatively affect transcription (Pan 
et al. 1996). The contributions of these residues was tested for the promoter F25CC(-40.5) in a Δfis genetic 
background complemented with wild type Fis or Fis containing an amino acid substitution (R71Y, E71K or 
G72A). When residue 71 is substituted for Y or K the expression is reduced by 50% when compared to wild type 
(WT+ Fis. When residue 72 is substituted for A expression is reduced to 25% of wild type. These results suggest 
residue 71 is one of a number of determinants for the interaction and when disrupted expression is reduced and 
when residue 72 is substituted for A the entire determinant region is disrupted reducing expression further. 
 
4.6 Discussion 
The emulation of pet promoter architecture in the model promoter allowed the effect of the pet promoter 
architecture to be assessed independently. These results tend to agree the proposed regulatory mechanisms that 
occur at the pet promoter, although there are a few inconsistencies that remained to be rectified. The first 
disparity between the promoter systems is the inability of an inserted fisII site to reduce the expression from the 
F35CC(-40.5) promoter (Figure 4.2). Previously the repressive action of the fisII site was taken as being due to 
several possibilities: a direct interaction with RNAP, sequestration of Fis from fisI site or a conformational 
change to promoter, with these mechanisms dependant on a function fisI site. From these results any direct 
interaction and sequestration of Fis are unlikely and can be ruled out as the architecture of the pet promoter was 
fully reconstructed, indeed with a higher affinity Fis binding site. A conformation model appears to be the most 
likely candidate, where the change in promoter conformation due to Fis binding at the fisII site in appears to only 
affect the pet promoter negatively presumably due to subtle sequence difference between the promoters.   
 
Fis is able to act as an activator in these promoters where the fisI site is postioned on the same side of the DNA 
helix as the CRP site; presumably this allows the two α subunits to interact with the two transcription factors 
(Figure 4.3). As fisI is placed at positions on the DNA helix other than that of peak positions (n=25, 35 & 45) the 
ability of Fis to induce expression was seen to the gradually diminishes until the induction by Fis is lost (n= 30, 
39, 40 & 41). The ability of promoters, where fisI is located adjacent to the peak positions (n= 24 & 26), to 
induce expression, albeit at lowers level, is accommodated by the flexibility of the α subunits linker region. The 
decrease in expression presumably occurs because of the higher free energy costs required for the complex to 
adopt suboptimal conformations. The optimal positions for the fisI site occur every 10 bp (1 revolution of the 
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DNA helix), the expression from the optimal positions increasing as the spacer between the fisI and crp sites 
decrease, lending credence to the possibility of a class I interaction. This trend is broken with the F15CC(-40.5) 
promoter, where Fis is no longer able to induce expression, likely as in this case the Fis binding site is located 
too close to the CRP binding site, causing a steric clash, preventing binding and subsequent activation. These 
results together hint at a direct interaction between Fis and α-CTD, but does not rule out the possibility of Fis 
acting as a conformational activator.   
 
Class I and II activation requires a direct interaction, between the transcription factor and specific residues of the 
α-CTD. These results show that the expressions from those promoters, which are activated by Fis, expressions 
are reduced when residue 273 is substituted with alanine. Whilst all of the promoters are negatively affected by 
the alanine substitutions of the CRP specific residues 271, 285 and 287, except F25CC(-40.5), the only promoter 
not affected by residue 271 (Figure 4.4). When F25CC(-40.5) is compared to F35CC(-40.5), residue 273 has a 
much greater effect on F25CC(-40.5) along with the inactivity of residue 271. This suggests the change the 
change in spacer length is having an effect on the interaction with Fis and the α-CTD channelling the interaction 
through fewer residues. This could explain why F25CC(-40.5) is more highly expressed, as reducing the strength 
of an unduly strong promoter can aid promoter escape and ultimately increase expression (Miroslavova and 
Busby 2006). A discrepancy in this experiment, is the reduced expression from the CC(-40.5) promoter due to 
the substitution of residue 261. CC(-40.5) has not been alanine screened before and the reduction in expression, 
due to the alanine substation of residue 261, might be an intinstic charaterisic of the CC(-40.5) promoter. These 
results require further evidence to provide improve the confidence in the existence of a direct interaction 
between Fis and α-CTD. 
 
Fis is able to interact with the α-CTD through determinants including residues 71 – 73. Substitution of residue 71 
can affect the direct electrostatic interaction with the α-CTD and substitution of residue 72 can disrupt the 
surrounding residues, abolishing the interaction with the α-CTD (McLeod et al 1999). Firstly the results show 
the when the pKK233-3 plasmid does not express Fis the levels of expression from F25CC(-40.5) are lower than 
that that when pKK233-3 expresses G72A Fis (Figure 4.5). Fis is responsible for repressing the expression of 
CRP in a manner not dependent on interactions with the α subunit. Therefore all of the pKK233-3 plasmids that 
express any of the Fis mutants are able to control the levels of CRP, whilst when pKK233-3 is does not express 
Fis repression does not occur, leading to higher levels of CRP and consequently higher levels of expression from 
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the F25CC(-40.5) promoter. When the residue 71 is substituted for Y/K the electrostatic interaction with the α-
CTD is disrupted leading to reduced levels of expression. When residue 72 is substituted expression   
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Figure 4.5: Impact of Amino Acid Substitutions Within Fis on F25CC(-40.5)  
β-galactosidase assay displaying the activities of F25pCC(40.5) constructs carried by pRW50 within E. coli 
BW25113 Δfis containing the either the PKK233-3 plasmid or the PKK233-3 plasmid containing WT Fis or Fis 
containing an amino acid substitution at position 71 (Y/K) or position 72 (A). Cell were grown anaerobically at 
37°C in LB broth until early log phase (OD650=0.4) and results are the average of three independent assays; 
standard deviation shown by error bars. 
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becomes even lower, this is consist with the idea that altering residue 72 disrupts the surrounding α-CTD 
interacting residues abolishing the interactions. These results collaborate with the α-CTD substitution and the 
spacer variation experiments, and leads to the conclusion that Fis activates transcription in a class I mechanism 
in the FnCC(-40.5) series.     
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Chapter 5 
Conclusions 
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The pathogenic properties of EAEC strain 042 result from the combination of several distinct processes, 
adherence to intestinal mucosa, biofilm formation and toxin expression, facilitated by the coordinated expression 
of many virulence factors including Pet, itself targeting α-fodrin, disrupting the actin cytoskeleton of host cells 
(Eslava et al. 1998; Nataro 2005; Croxen and Finlay 2010). The expression of Pet is governed by the global 
transcription factors CRP and Fis, CRP activating transcription from a non-canonical bindings site (-40.5), with 
further enhancement provided by Fis bound at the fisI site (-91) (Rossiter et al. 2011). When EAEC shifts from a 
nutrient limited to a nutrient rich environment it soon enters the log phase of growth where levels of cAMP fall 
resulting in the gradual repression of both CRP (Hanamura and Aiba 1991; Nasser et al. 2001). However Pet 
expression occurs in a temporal window at the initiation of nutrient upshift where a transient peak of Fis 
expression occurs; expression of Pet tailing off as the levels of active CRP are depleted (Ball et al. 1992). This 
mechanism of co-activation allows the expression of Pet to be restricted to early log phase when EAEC 
encounters a nutrient rich environment to compete with the host microbiome and initiate infection (Betancourt-
Sanchez and Navarro-Garcia 2009). 
 
Previous work was able to show transcription regulation of pet expression is dependent on CRP and Fis. The 
worked assessed the mechanisms employed to affect transcription to regulate transcription. CRP activates 
transcription through a class II mechanism from its non-canonical binding site; this interaction dependant on the 
residues 185, 187 and 173 of the α-CTD and AR1 and AR2 of CRP (Figure 4.4) (Fig. S3 Rossiter et al. 2011). 
Fis was known to play an important role in the regulation of the pet promoter, activating from the fisI site and 
repressing from the fisII site. Fis has been shown to function as an activator from the fisI site when CRP is 
bound to the promoter, facilitated by residues 173 and 171 of the α-CTD and residues 71 and 73 of Fis (Figure 
4.4; Figure 4.5). The dependence on these residues of Fis and the α-CTD alongside the helical phasing 
dependence (Figure 3.3; Figure 4.3) strongly suggests a Fis dependant class I interaction, from the fisI site, 
induces transcription. The reason for the dependence on the presence of a bound CRP for the functioning of Fis 
has yet to be fully established, although it seems likely the DNA bending provided by CRP compensates for the 
limited length of the α subunit linker region and the larger spacer between fisI and the -10 element, allowing the 
interaction to occur. The second Fis binding site, fisII, was shown to be repressive in the pet promoter; despite 
further work the underlying mechanism remains elusive (Figure 3.2) (Rossiter et al. 2011). The compilation of 
the results presented delivers the most complete model yet for the transcription regulation of the pet promoter 
(Figure 5.1). In summary, this study has been able to provide some deeper understanding of the principal 
interactions that regulate the expression of the pet promoter, with the focus residing on the fisI site.  
 
 
57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Model of Transcription Regulation at the pet Promoter  
Model displaying the proposed interactions implicated in transcription regulation at the pet promoter. The yellow 
stars indicate the location of direct interactions with the residues of the transcription factor and α-CTD confirmed 
to be involved in induction of transcription. CRP binds to the non-canonical DNA binding site, causing the DNA 
to bend; presumably the DNA bending facilitates the interaction between Fis, bound at fisI, and RNAP.  
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Nevertheless, there are many questions regarding of the pet system that remain unanswered; the effect of DNA 
bending on the interaction between Fis and RNAP, the specific residues responsible for the interaction between 
α-CTD and each transcription factor, and the repressive nature of the fisII site. Further understanding the pet 
promoter will underpin the understanding of other promoters of virulence factors of related architecture (Rossiter 
et al. 2011). 
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